Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis

NCT: NCT07412249 · RECRUITING

NCT IDNCT07412249
StatusRECRUITING
Start Date2026-03-04
Completion2027-11-30

Brief Summary

Remote ischemic conditioning (RIC) has emerged as a promising non-invasive strategy to protect the brain, with evidence suggesting its benefit in patients with carotid artery stenting (CAS). However, the long-term benefit and safety of chronic RIC in this population remain unknown. This trial aims to evaluate whether chronic RIC reduces the incidence of major vascular events and improves clinical outcomes in high-risk patients with carotid artery stenosis who received CAS.

Frequently Asked Questions

What is Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis?

Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis is a clinical trial registered under NCT07412249. Current status: RECRUITING.

What is the status of NCT07412249?

The current status of NCT07412249 (Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis) is: RECRUITING.

When did Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis start?

Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis started on 2026-03-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.